Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001410939-21-000013
Filing Date
2021-04-07
Accepted
2021-04-07 16:09:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A additionalproxymaterialsfo.htm DEFA14A 16445
2 a03fs6c_ivericxbioxnoticex.jpg GRAPHIC 1229455
3 a03fs6c_ivericxbioxnoticexa.jpg GRAPHIC 265829
  Complete submission text file 0001410939-21-000013.txt   2076964
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36080 | Film No.: 21812225
SIC: 2834 Pharmaceutical Preparations